SBFM
Income statement / Annual
Last year (2024), Sunshine Biopharma, Inc.'s total revenue was $34.87 M,
an increase of 44.75% from the previous year.
In 2024, Sunshine Biopharma, Inc.'s net income was -$5.13 M.
See Sunshine Biopharma, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
| Operating Revenue |
$34.87 M |
$24.09 M |
$4.35 M |
$228,426.00 |
$71,410.00 |
$21,121.00 |
$447,200.00 |
$0.00 |
$0.00 |
$1,708.00 |
| Cost of Revenue |
$24.20 M
|
$15.75 M
|
$2.65 M
|
$117,830.00
|
$25,847.00
|
$11,050.00
|
$391,081.00
|
$6,629.00
|
$60,731.00
|
$384,581.00
|
| Gross Profit |
$10.67 M
|
$8.34 M
|
$1.70 M
|
$110,596.00
|
$45,563.00
|
$10,071.00
|
$56,119.00
|
-$6,629.00
|
-$60,731.00
|
-$382,873.00
|
| Gross Profit Ratio |
0.31
|
0.35
|
0.39
|
0.48
|
0.64
|
0.48
|
0.13
|
0
|
0
|
-224.16
|
| Research and Development Expenses |
$0.00
|
$1.86 M
|
$811,858.00
|
$672,209.00
|
$60,948.00
|
$15,204.00
|
$12,800.00
|
$0.00
|
$32,793.00
|
$8,657.00
|
| General & Administrative Expenses |
$16.48 M
|
$10.10 M
|
$8.90 M
|
$1.87 M
|
$547,423.00
|
$622,729.00
|
$1.21 M
|
$850,561.00
|
$899,584.00
|
$769,077.00
|
| Selling & Marketing Expenses |
$940,278.00
|
$734,248.00
|
$578,085.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$17.42 M
|
$10.83 M
|
$9.48 M
|
$1.87 M
|
$547,423.00
|
$622,729.00
|
$1.21 M
|
$850,561.00
|
$899,584.00
|
$769,077.00
|
| Other Expenses |
$0.00
|
$438,884.00
|
$80,396.00
|
$12,741.00
|
$14,066.00
|
$13,774.00
|
-$871,726.00
|
-$76,929.00
|
$60,731.00
|
$4,251.00
|
| Operating Expenses |
$17.42 M
|
$13.12 M
|
$10.37 M
|
$2.55 M
|
$622,437.00
|
$651,707.00
|
$1.22 M
|
$857,190.00
|
$993,108.00
|
$781,985.00
|
| Cost And Expenses |
$41.63 M
|
$28.88 M
|
$13.02 M
|
$2.67 M
|
$648,284.00
|
$662,757.00
|
$1.61 M
|
$857,190.00
|
$993,108.00
|
$781,985.00
|
| Interest Income |
$496,003.00
|
$811,974.00
|
$518,650.00
|
$328,818.00
|
$168,105.00
|
$115,901.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Interest Expense |
-$8,774.00
|
$137,308.00
|
$39,412.00
|
$328,818.00
|
$168,105.00
|
$115,901.00
|
$159,420.00
|
$104,829.00
|
$34,732.00
|
$307,211.00
|
| Depreciation & Amortization |
$223,527.00
|
$149,147.00
|
$25,163.00
|
$12,741.00
|
$14,066.00
|
$13,774.00
|
$49,361.00
|
$6,629.00
|
$60,731.00
|
$4,251.00
|
| EBITDA |
-$5.15 M |
-$3.82 M |
-$26.45 M |
-$12.09 M |
-$2.60 M |
-$948,380.00 |
-$1.95 M |
-$928,780.00 |
-$932,377.00 |
-$1.34 M |
| EBITDA Ratio |
-0.15
|
-0.16
|
-6.09
|
-52.95
|
-36.44
|
-44.9
|
-4.35
|
0
|
0
|
-785.39
|
| Operating Income Ratio |
-0.17
|
-0.2
|
-2
|
-10.68
|
-8.08
|
-30.38
|
-2.61
|
0
|
0
|
-456.84
|
| Total Other Income/Expenses Net |
$443,147.00
|
$674,422.00
|
$489,614.00
|
-$10.00 M
|
-$2.21 M
|
-$436,418.00
|
-$989,618.00
|
-$183,046.00
|
-$2.50 M
|
-$872,631.00
|
| Income Before Tax |
-$5.37 M
|
-$4.11 M
|
-$26.51 M
|
-$12.44 M
|
-$2.78 M
|
-$1.08 M
|
-$2.16 M
|
-$1.04 M
|
-$3.50 M
|
-$1.65 M
|
| Income Before Tax Ratio |
-0.15
|
-0.17
|
-6.1
|
-54.44
|
-38.99
|
-51.04
|
-4.82
|
0
|
0
|
-967.74
|
| Income Tax Expense |
-$234,858.00
|
$395,166.00
|
$233,304.00
|
$328,818.00
|
-$1.89 M
|
$383,386.00
|
-$41,528.00
|
$1,288.00
|
$2.47 M
|
$565,420.00
|
| Net Income |
-$5.13 M
|
-$4.51 M
|
-$26.74 M
|
-$12.77 M
|
-$897,683.00
|
-$1.46 M
|
-$2.16 M
|
-$1.04 M
|
-$3.50 M
|
-$1.65 M
|
| Net Income Ratio |
-0.15
|
-0.19
|
-6.15
|
-55.88
|
-12.57
|
-69.19
|
-4.82
|
0
|
0
|
-967.74
|
| EPS |
-7.32 |
-370.41 |
-3523.64 |
-9774.32 |
-1036.59 |
-828.01 |
-141.54 |
-23.84 |
-164.63 |
-270.44 |
| EPS Diluted |
-7.32 |
-370.41 |
-3523.64 |
-9774.32 |
-1036.59 |
-828.01 |
-141.54 |
-23.84 |
-164.63 |
-270.44 |
| Weighted Average Shares Out |
$701,749.00
|
$12,165.00
|
$7,590.00
|
$1,306.00
|
$866.00
|
$1,765.00
|
$15,234.00
|
$43,632.00
|
$21,240.00
|
$1,528.00
|
| Weighted Average Shares Out Diluted |
$701,749.00
|
$12,165.00
|
$7,590.00
|
$1,306.00
|
$866.00
|
$1,765.00
|
$15,234.00
|
$43,632.00
|
$21,240.00
|
$1,528.00
|
| Link |
|
|
|
|
|
|
|
|
|
|
